Sept 15 - Britain's FTSE 100 .FTSE index is seen opening six points higher
at 6,032 on Tuesday, according to financial bookmakers.
* ASTRAZENECA: AstraZeneca's AZN.L COVID-19 vaccine trial remains on hold
in the United States pending a U.S. investigation into a serious side effect in
Britain even as other trials of the vaccine resume, sources familiar with the
details told Reuters. * G4S: Britain's G4S GFS.L said on Monday it had rejected a 2.95 billion
pound offer from Canadian security firm GardaWorld, saying it was "highly
opportunistic". * GOLD: Gold prices rose on Tuesday as the dollar remained subdued, with
investors turning their focus to a U.S. Federal Reserve monetary policy meeting,
seeking details of its plans on inflation targeting. * OIL: Oil prices slipped on Tuesday as worries over slow recovery in global
fuel demand were reinforced by warnings by major oil producers, but
short-covering ahead of a meeting later this week of OPEC and its allies, known
as OPEC+, limited losses. * The UK blue-chip index .FTSE shed 0.1% on Monday, as the prospect of
waning demand weighed on heavyweight energy stocks, while security firm G4S
propped up the midcap index after it rejected a takeover from Canadia's
GardaWorld. UK CORPORATE DIARY:
Eve Sleep Plc EVEE.L HY results
Ocado Plc OCDO.L Q3 trading statement
Marshalls Plc MSLH.L HY results
Polypipe Group Plc PLP.L HY results
Jtc Plc JTC.L HY results
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB